Cargando…

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis

Background: Metastatic intrahepatic cholangiocarcinoma still has a dismal prognosis. The aim of our study was to investigate the prognostic role of bone metastases in patients affected by intrahepatic cholangiocarcinoma. Methods: A total of 186 metastatic intrahepatic cholangiocarcinoma patients wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garajová, Ingrid, Gelsomino, Fabio, Salati, Massimiliano, Leonardi, Francesco, De Lorenzo, Stefania, Granito, Alessandro, Tovoli, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047338/ https://www.ncbi.nlm.nih.gov/pubmed/36975412 http://dx.doi.org/10.3390/curroncol30030199

Ejemplares similares

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
por: Garajová, Ingrid, et al.
Publicado: (2023)

Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials
por: Tovoli, Francesco, et al.
Publicado: (2021)

Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
por: De Lorenzo, Stefania, et al.
Publicado: (2020)

Should patients on levothyroxine therapy be screened for pancreatic cancer?
por: Garajová, Ingrid, et al.
Publicado: (2022)

A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists
por: Garajová, Ingrid, et al.
Publicado: (2023)

The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting
por: Salati, Massimiliano, et al.
Publicado: (2021)

Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis
por: Tovoli, Francesco, et al.
Publicado: (2018)

Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management
por: Gelsomino, Fabio, et al.
Publicado: (2022)

Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma
por: Ielasi, Luca, et al.
Publicado: (2023)

Treatment of Combined Hepatocellular and Cholangiocarcinoma
por: Leoni, Simona, et al.
Publicado: (2020)

Effect of age on the prognosis of intrahepatic cholangiocarcinoma
por: Kim, Jung Hun, et al.
Publicado: (2023)

Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection
por: Garajova, Ingrid, et al.
Publicado: (2021)

Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition
por: Medici, Bianca, et al.
Publicado: (2023)

Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases
por: De, Brian, et al.
Publicado: (2023)

Autoantibodies to speckled protein family in primary biliary cholangitis
por: Granito, Alessandro, et al.
Publicado: (2021)

Anti-ganglioside antibodies and celiac disease
por: Granito, Alessandro, et al.
Publicado: (2021)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
por: Lamarca, Angela, et al.
Publicado: (2021)

Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5)
por: Terzi, Eleonora, et al.
Publicado: (2022)

The Tumor Microenvironment Drives Intrahepatic Cholangiocarcinoma Progression
por: Mancarella, Serena, et al.
Publicado: (2022)

Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022)

Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?
por: Sweigert, Patrick J., et al.
Publicado: (2020)

Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept
por: De Lorenzo, Stefania, et al.
Publicado: (2018)

The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
por: Pietri, Elisabetta, et al.
Publicado: (2021)

Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
por: Gadaleta-Caldarola, Gennaro, et al.
Publicado: (2022)

Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC
por: Granito, Alessandro, et al.
Publicado: (2021)

COVID-19: Has the Liver Been Spared?
por: Brandi, Nicolò, et al.
Publicado: (2023)

Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2019)

SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018)

Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma
por: Fu, Kui, et al.
Publicado: (2020)

High expression of HVEM is associated with improved prognosis in intrahepatic cholangiocarcinoma
por: Ma, Bingqi, et al.
Publicado: (2021)

Correction: Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022)

Epigenetic dysregulation-mediated COL12A1 upregulation predicts worse outcome in intrahepatic cholangiocarcinoma patients
por: Tang, Zengwei, et al.
Publicado: (2023)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Update of the Bologna Experience in Radioembolization of Intrahepatic cholangiocarcinoma
por: Mosconi, Cristina, et al.
Publicado: (2023)

Systemic treatments for hepatocellular carcinoma: challenges and future perspectives
por: Tovoli, Francesco, et al.
Publicado: (2018)

Current guidelines for the management of celiac disease: A systematic review with comparative analysis
por: Raiteri, Alberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_82uvog29etus5otl6hv12796qa